miR-204–containing exosomes ameliorate GVHD-associated dry eye disease

T Zhou, C He, P Lai, Z Yang, Y Liu, H Xu, X Lin, B Ni… - Science …, 2022 - science.org
Graft-versus-host disease (GVHD)–associated dry eye disease is characterized by extensive
inflammatory destruction in the ocular surface and causes unbearable pain and visual …

[HTML][HTML] Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye

MJ Lee, AY Ko, JH Ko, HJ Lee, MK Kim, WR Wee… - Molecular Therapy, 2015 - cell.com
Dry eye syndrome (DES) is one of the most common ocular diseases affecting nearly 10% of
the US population. Most of the currently available treatments are palliative, and few …

[HTML][HTML] Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis

L Bai, H Shao, H Wang, Z Zhang, C Su, L Dong, B Yu… - Scientific reports, 2017 - nature.com
We previously demonstrated that mesenchymal stem cells (MSCs) ameliorated experimental
autoimmune uveoretinitis (EAU) in rats. Recently, MSC-derived exosomes (MSC-Exo) were …

[HTML][HTML] Exosomes derived from mouse adipose-derived mesenchymal stem cells alleviate benzalkonium chloride-induced mouse dry eye model via inhibiting NLRP3 …

G Wang, H Li, H Long, X Gong, S Hu, C Gong - Ophthalmic Research, 2022 - karger.com
Purpose: The objective of the study was to investigate efficacy and mechanisms of mouse
adipose-derived mesenchymal stem cell-derived exosomes (mADSC-Exos) in the …

[HTML][HTML] Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1

W Zhang, Y Wang, Y Kong - Investigative ophthalmology & …, 2019 - iovs.arvojournals.org
Purpose: In this study, we aim to investigate whether mesenchymal stem cell (MSC)-derived
exosomes (MSC-Exos) could regulate hyperglycemia-induced retinal inflammation by …

[HTML][HTML] TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p …

Z Yu, Y Wen, N Jiang, Z Li, J Guan, Y Zhang, C Deng… - Biomaterials, 2022 - Elsevier
Retinal ischemia-reperfusion injury (IRI) is one of the main pathogenic mechanisms of
glaucoma, which are largely unknown, including neuroinflammation and neuronal death in …

Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases

CR Harrell, B Simovic Markovic, C Fellabaum… - Cell Biology and …, 2018 - Springer
Mesenchymal stem cells (MSCs) were, due to their immunomodulatory and pro-angiogenic
characteristics, extensively explored as new therapeutic agents in cell-based therapy of …

[HTML][HTML] Mesenchymal stem cell-derived extracellular vesicles protect retina in a mouse model of retinitis pigmentosa by anti-inflammation through miR-146a-Nr4a3 …

J Zhang, P Li, G Zhao, S He, D Xu, W Jiang… - Stem Cell Research & …, 2022 - Springer
Background Retinitis pigmentosa is a rod-cone degenerative disease that induces
irreversible vision loss. This study probed the protective capacity of mesenchymal stem cell …

[HTML][HTML] hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye

C Yu, P Chen, J Xu, Y Liu, H Li, L Wang, G Di - Scientific reports, 2020 - nature.com
The present study was set out to address the therapeutic efficacy of human adipose tissue
stem cells derived extracellular vesicles (hADSC-Evs) in a mouse model of dry eye disease …

Mesenchymal stem cell exosomes as nanotherapeutics for dry age-related macular degeneration

Y Tang, Y Kang, X Zhang, C Cheng - Journal of Controlled Release, 2023 - Elsevier
Oxidative stress-induced retinal pigment epithelial (RPE) cell damage is a major factor in the
pathogenesis of dry age-related macular degeneration (AMD). Although the therapeutic …